Table 3.
Participant demographics and baseline characteristics associated with product choice at month 3 and unwillingness to use the product in the future. (N = 249)
| Choice | Disinterest/unwilling to use in the future | |||
|---|---|---|---|---|
| TRIO Product | Adjusted OR (95% CI) | p‐value | Adjusted OR (95% CI) | p‐value |
| Tablets | ||||
| Has privacy in the home | 0.47 (0.22, 1.01) | 0.05 | 2.36 (1.08, 5.14) | 0.03 |
| Ring | ||||
| Have own source of income | 0.53 (0.23, 1.24) | 0.14 | 2.05 (1.09, 3.85) | 0.03 |
| Does not have a casual sex partner | 0.55 (0.24, 1.23) | 0.14 | 2.01 (1.02, 3.94) | 0.04 |
| Nulliparous | 0.99 (0.40, 2.49) | 0.99 | 1.99 (1.03, 3.86) | 0.04 |
| Has privacy in the home | 2.29 (0.73, 7.21) | 0.16 | 0.38 (0.18, 0.80) | 0.01 |
No characteristics were significantly associated (p < 0.05) with choice or disinterest in injections. Here, p‐values from logistic regression models adjusted for country, randomization sequence, and age. CI, confidence interval.